Literature DB >> 26608518

Tissue engineering strategies for promoting vascularized bone regeneration.

Sarah Almubarak1, Hubert Nethercott1, Marie Freeberg1, Caroline Beaudon1, Amit Jha2, Wesley Jackson2, Ralph Marcucio3, Theodore Miclau3, Kevin Healy2, Chelsea Bahney4.   

Abstract

This review focuses on current tissue engineering strategies for promoting vascularized bone regeneration. We review the role of angiogenic growth factors in promoting vascularized bone regeneration and discuss the different therapeutic strategies for controlled/sustained growth factor delivery. Next, we address the therapeutic uses of stem cells in vascularized bone regeneration. Specifically, this review addresses the concept of co-culture using osteogenic and vasculogenic stem cells, and how adipose derived stem cells compare to bone marrow derived mesenchymal stem cells in the promotion of angiogenesis. We conclude this review with a discussion of a novel approach to bone regeneration through a cartilage intermediate, and discuss why it has the potential to be more effective than traditional bone grafting methods.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Bone regeneration; Controlled release; Endochondral ossification; Osteogenesis; Stem cells

Mesh:

Substances:

Year:  2015        PMID: 26608518      PMCID: PMC4911893          DOI: 10.1016/j.bone.2015.11.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  210 in total

1.  Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?

Authors:  Gun-Il Im; Yong-Woon Shin; Kee-Byung Lee
Journal:  Osteoarthritis Cartilage       Date:  2005-10       Impact factor: 6.576

2.  Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate.

Authors:  Amit K Jha; Anurag Mathur; Felicia L Svedlund; Jianqin Ye; Yerem Yeghiazarians; Kevin E Healy
Journal:  J Control Release       Date:  2015-04-27       Impact factor: 9.776

3.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

4.  Early endothelial progenitor cells as a source of myeloid cells to improve the pre-vascularisation of bone constructs.

Authors:  Y Shi; G Kramer; A Schröder; C J Kirkpatrick; A Seekamp; H Schmidt; S Fuchs
Journal:  Eur Cell Mater       Date:  2014-01-25       Impact factor: 3.942

5.  Angiogenesis in bone regeneration.

Authors:  Kurt D Hankenson; Michael Dishowitz; Chancellor Gray; Mara Schenker
Journal:  Injury       Date:  2011-04-12       Impact factor: 2.586

Review 6.  Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Authors:  Gian Paolo Fadini; Douglas Losordo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

Review 7.  Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications.

Authors:  Michele De Palma; Craig Murdoch; Mary Anna Venneri; Luigi Naldini; Claire E Lewis
Journal:  Trends Immunol       Date:  2007-11-05       Impact factor: 16.687

8.  Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia.

Authors:  F A Kudo; T Nishibe; M Nishibe; K Yasuda
Journal:  Int Angiol       Date:  2003-12       Impact factor: 2.789

9.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

Authors:  Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble
Journal:  Cytotherapy       Date:  2013-04-06       Impact factor: 5.414

10.  The use of rhBMP in spine surgery: is there a cancer risk?

Authors:  John G Devine; Joseph R Dettori; John C France; Erika Brodt; Robert A McGuire
Journal:  Evid Based Spine Care J       Date:  2012-05
View more
  46 in total

1.  Injectable shear-thinning hydrogels for delivering osteogenic and angiogenic cells and growth factors.

Authors:  Emine Alarçin; Tae Yong Lee; Sobha Karuthedom; Marzieh Mohammadi; Meadhbh A Brennan; Dong Hoon Lee; Alessandra Marrella; Jin Zhang; Denata Syla; Yu Shrike Zhang; Ali Khademhosseini; Hae Lin Jang
Journal:  Biomater Sci       Date:  2018-05-29       Impact factor: 6.843

Review 2.  The Use of Adipose Tissue-Derived Progenitors in Bone Tissue Engineering - a Review.

Authors:  Indranil Bhattacharya; Chafik Ghayor; Franz E Weber
Journal:  Transfus Med Hemother       Date:  2016-09-15       Impact factor: 3.747

3.  Dual non-viral gene delivery from microparticles within 3D high-density stem cell constructs for enhanced bone tissue engineering.

Authors:  Alexandra McMillan; Minh Khanh Nguyen; Tomas Gonzalez-Fernandez; Peilin Ge; Xiaohua Yu; William L Murphy; Daniel J Kelly; Eben Alsberg
Journal:  Biomaterials       Date:  2018-01-03       Impact factor: 12.479

4.  Evaluation of an Engineered Hybrid Matrix for Bone Regeneration via Endochondral Ossification.

Authors:  Paiyz E Mikael; Aleksandra A Golebiowska; Xiaonan Xin; David W Rowe; Syam P Nukavarapu
Journal:  Ann Biomed Eng       Date:  2019-04-29       Impact factor: 3.934

Review 5.  Bioprinting: From Tissue and Organ Development to in Vitro Models.

Authors:  Carlos Mota; Sandra Camarero-Espinosa; Matthew B Baker; Paul Wieringa; Lorenzo Moroni
Journal:  Chem Rev       Date:  2020-05-14       Impact factor: 60.622

6.  Bone morphogenetic protein 9 (BMP9) induces effective bone formation from reversibly immortalized multipotent adipose-derived (iMAD) mesenchymal stem cells.

Authors:  Shun Lu; Jing Wang; Jixing Ye; Yulong Zou; Yunxiao Zhu; Qiang Wei; Xin Wang; Shengli Tang; Hao Liu; Jiaming Fan; Fugui Zhang; Evan M Farina; Maryam M Mohammed; Dongzhe Song; Junyi Liao; Jiayi Huang; Dan Guo; Minpeng Lu; Feng Liu; Jianxiang Liu; Li Li; Chao Ma; Xue Hu; Michael J Lee; Russell R Reid; Guillermo A Ameer; Dongsheng Zhou; Tongchuan He
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

Review 7.  Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.

Authors:  Tianxin Miao; Junqing Wang; Yun Zeng; Gang Liu; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2018-01-08       Impact factor: 16.806

8.  [Preparation of aspirin sustained-release microsphere and its in vitro releasing property].

Authors:  Y Chen; Z N Liu; B Li; T Jiang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-10-18

Review 9.  Bone physiology as inspiration for tissue regenerative therapies.

Authors:  Diana Lopes; Cláudia Martins-Cruz; Mariana B Oliveira; João F Mano
Journal:  Biomaterials       Date:  2018-09-17       Impact factor: 12.479

10.  Fabrication of a nanoparticle-containing 3D porous bone scaffold with proangiogenic and antibacterial properties.

Authors:  Juan L Paris; Nuria Lafuente-Gómez; M Victoria Cabañas; Jesús Román; Juan Peña; María Vallet-Regí
Journal:  Acta Biomater       Date:  2019-01-14       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.